Abstract
Two of the numerous aspects of the biology of host-tumour interaction and their implications for the cancer patient have been of major concern to tumour immunologists during the past 20 years (Table 12.1). The first of these has been the demonstration that many, if not all, tumour cells express constituents that are absent, or virtually absent, from corresponding normal cells. Since these cellular components have been sought and found by means of immunologic technology, they are collectively termed tumour-specific antigens (TSA).
Portions of the work reviewed were supplied by the National Cancer Institute of Canada, Toronto, Canada; the Medical Research Council of Canada, Toronto, Canada; and the Cancer Research Society, Inc., Montreal, Canada
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Foley, E. J. (1953). Antigenic properties of methylcholanthrene-induced tumors in mice of strain of origin. Cancer Res., 13, 835
Klein, G. and Klein, E. (1977). Immune surveillance against virus-induced tumors and non-rejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution. Proc. Nat. Acad. Set. USA, 74, 2121
Kersey, J. H., Spector, B. D. and Good, R. A. (1974). Cancer in children with primary immunodeficiency diseases. J. Pediat., 84, 263
Penn, I. (1974). Occurrence of cancer in immune deficiencies. Cancery 34, 858
Shuster, J. (1976). Hypergammaglobulinemia and paraproteinemia. In: Clinical Immunology, 2nd Edition (S. O. Freedman and P. Gold, eds.), p. 358. (Hagerstown, Maryland: Harper and Row Publishers)
Brown, R. S., Haynes, H. A., Foley, H. T., Godwin, H. A., Berard, C. W. and Carbone, P. P. (1967). Hodgkin’s disease; immunologic, clinical, and histologic failures on 50 untreated patients. Ann. Intern. Med., 67, 291
Kopersztych, S., Rezkallah, M. T., Miki, S. S., Naspitz, C. K. and Mendes, N. F. (1976). Cellmediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence. Cancer, 38, 1149.
Brunschwig, A., Southam, C. M. and Levin, A. G. (1965). Host resistance to cancer: clinical experiments by homotransplants, autotransplants and admixture of autologous leucocytes. Ann. Surg., 162, 416
Grace, J. T., Perese, D. M., Metzgar, R. S., Sasabe, T. and Holdridge, B. (1961). Tumor autograft responses in patients with glioblastoma multiforme. J. Neurosurg., 18, 159
Southam, C. M. (1967). Evidence for cancer-specific antigens in man. Progr. Exp. Tumor Res., 9,1
Hughes, L. E. and Lytton, B. (1964). Antigenic properties of human tumours; delayed cutaneous hypersensitivity reactions. Br. Med. J., 1, 209
Stewart, T. H. M. (1969). The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 1. The role of tissue antigen, nonspecific reactions of nuclear material, and bacterial antigen as a cause for this phenomenon. Cancery 23, 1368
Stewart, T. H. M. and Orizaga, M. (1971). The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 3. The frequency, duration and cross-reactivity of this phenomenon in patients with breast cancer, and its correlation with survival. Cancer, 28, 1472
Oren, M. E. and Herberman, R. B. (1971). Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells. Clin. Exp. Immunol. 9, 45
Char, D. H., Lepourhiet, A., Leventhal, B. G. and Herberman, R. B. (1973). Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia. Cancer, 12, 409
Gutterman, J. U., Hersh, E. M., Freireich, E. J., Rossen, R. D., Butler, W. T., McCredie, K. B., Bodeh, G. P., Sr., Rodriguez, V. and Mavligit, G. M. (1973). Cell-mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen: relationship to im-munocompetence and prognosis. Nat. Cancer Inst. Monogr., 37,153
Hollinshead, A. C. and Herberman, R. B. (1974). Identification and characterization: cell membrane antigens specific for the blast phase of leukemia, p. 339, Proc. 4th Int. Symp. Comp. Leukemia Res., 6th, Nagoya
Hollinshead, A. C., Glew, D., Bunnag, B., Gold, P. and Herberman, R. (1970). Skin-reactive soluble antigen from intestinal cancer cell membranes and relationship to carcinoembryonic antigens. Lancet, i, 1191
Hollinshead, A., McWright, C. G., Alford, T. C., Glew, D. H., Gold, P. and Herberman, R. B. (1972). Separation of skin-reactive intestinal cancer antigen from the carcinoembryonic antigen of Gold. Science, 177,887
Pass, L., Herberman, R. B., Ziegler, J. L. and Kiryabwire, J. W. M. (1970). Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells. Lancet, i, 116
Bluming, A. Z., Vogel, C. L., Tiegler, J. L. and Kiryabwire, J. W. M. (1972). Delayed cutaneous sensitivity reactions to extracts on autologous malignant melanoma: a second look. J. Nat. Cancer Inst, 48,17
Hollinshead, A. C., Jaflfurs, W. T., Aljrt, L. K., Harris, J. E. and Herberman, R. B. (1974). Isolation and identification on soluble skin-reactive membrane antigens of malignant and normal human breast cells. Cancer Res., 34, 2961
Hollinshead, A. C., Herberman, R. B., Jaffurs, W. J., Alpert, L. K., Minton, J. P. and Harris, J. E. (1974). Soluble membrane antigens of human malignant melanoma cells. Cancer, 34, 1235
Alford, C., Hollinshead, A. C. and Herberman, R. B. (1973). Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal human breast cells. Ann. Surg., 178, 20
Black, M. M. and Leis, H. P. (1971). Cellular responses to autologous breast cancer tissue. Cancer, 28, 263
Char, D. H., Hollinshead, A. C., Cogan, D. G., Ballantine, E. J., Hogan, M. J. and Herberman, R. B. (1974). Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma. N. Engl. J. Med., 291, 274
Hellstrom, I., Hellstrom, K. E., Pierce, G. E. and Bill, A. H. (1968). Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc. Nat. Acad. Sci. USA, 60, 1231
Hellstrom, I. and Hellstrom, K. E. (1971). Colony inhibition and cytotoxicity assays. In: In Vitro Methods in Cell-Mediated Immunity (B. R. Bloom and P. R. Glade, eds.), p. 409. (New York: Academic Press)
Herberman, R. B. and Oldham, R. K. (1975). Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays. J. Nat. Cancer Inst., 55, 749
Baldwin, R. W. (1975). In vitro assays of cell-mediated immunity to human solid tumors: problems of quantitation, specificity, and interpretation. J. Nat. Cancer Inst., 55, 745
Cochran, A. J., Spilg, W. G. S., Mackie, R. M. and Thomas, C. E. (1972). Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br. Med. J., 4, 67
McCoy, J. L., Jerome, L. F., Dean, J. H., Perlin, E., Oldham, R. K., Char, D. H., Cohen, M. H., Felix, E. L. and Herberman, R. B. (1975). Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of malignant melanoma. J. Nat. Cancer Inst., 55,19
McCoy, J. L., Jerome, L. F., Dean, J. H., Cannon, G. B., Alford, T. C., Doering, T. and Herberman, R. B. (1974). Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma. J. Nat. Cancer Inst., 53,11
Bull, D. M., Leibach, J. R., Williams, M. A. and Helms, R. A. (1973). Immunity to colon cancer assessed by antigen-induced inhibition of mixed mononuclear cell migration. Science, 181,957
Braun, M., Sen, L., Backmann, A. E. and Pavlovsky, A. (1972). Cell migration inhibition in human lymphomas using lymph node and cell line antigens. Blood, 39, 368
Halliday, W. J. and Miller, S. (1972). Leukocyte adherence inhibition: a simple test for cellmediated tumour immunity and serum blocking factors. Int. J. Cancer, 9, 477
Holan, V., Hasek, M., Bubenik, J. and Chutno, J. (1974) Antigen-mediated macrophage adherence inhibition. Cell Immunol., 13, 107
Grosser, N. and Thomson, D. M. P. (1975). Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Cancer Res., 35,2571
Marti, J. H. and Thomson, D. M. P. (1976). Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition. Br. J. Cancer, 34, 116
Rutherford, J. C., Walters, B. A. J., Cavaye, G. and Halliday, W. J. (1977). A modified leukocyte adherence inhibition test in the laboratory investigation of gastrointestinal cancer. Int. J. Cancer, 19, 43
Powell, A. E., Sloss, A. M., Smith, R. N., Makley, J. T. and Hubay, C. A. (1975). Specific responsiveness of leukocytes to soluble extracts of human tumors. Int. J. Cancer, 16,905
Grosser, N., Marti, J. H., Proctor, J. W. and Thomson, D. M. P. (1976). Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. I. Monocyte is the reactive cell. Int. J. Cancer, 18, 39
Marti, J. H., Grosser, N. and Thomson, D. M. P. (1976). Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity. II. Monocyte reacts with tumor antigen via cytophilic anti-tumor antibody. Int. J. Cancer, 18, 48
Grosser, N. and Thomson, D. M. P. (1976). Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumor antigen. III. Blockade of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients. Int. J. Cancer, 18, 58
Halliday, W. J., Maluish, A., Little, J. H. and Davis, N. C. (1975). Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma. Int. J. Cancer, 16, 645
Flores, M., Marti, J. H., Grosser, N., MacFarlane, J. K. and Thomson, D. M. P. (1977). An overview: anti-tumor immunity in breast cancer assayed by tube leukocyte adherence inhibition. Cancer, 39,494
Sanner, T., Brennhoud, I., Christensen, I., Jorgensen, O. and Kvaloy, S. (1977). Scand. J. Clin. Lab. Invest. Suppl., No. 147, Abstr. 172
Fujisawa, T., Waldman, S. R. and Yonemoto, R. H. (1977). Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients. Cancer, 39, 506
Holt, P. G., Chalmer, J. and Keast, D. (1975). Development of two manifestations of Tlymphocyte reactivity during tumor growth - altered kinetics associated with elevated growth rates. J. Nat. Cancer Inst., 55,1135
Halliday, W. J., Halliday, J. W., Campbell, C. B., Maluish, A. E. and Powell, L. W. (1974). Specific immunodiagnosis of hepatocellular carcinoma of leucocyte adherence inhibition. Br. Med. J., 2, 349
Maluish, A. E., Halliday, W. J., Bartley, P. C. and Lloyd, H. M. (1976). Immunological reactions in medullary carcinoma of the thyroid. Clin. Immunol. Immunopathol., 5, 303
Maluish, A. E. and Halliday, W. J.(1975). Quantitation of anti-tumor cell-mediated immunity by a lymphokine-dependent reaction using small volumes of blood. Cell Immunol., 17, 131
Hall, T. C. (1974). Oncocognitive autoimmunity and other paraneoplastic syndromes yet to be described. Ann. N. Y. Acad. Sci., 230, 565
Pearse, A. G. E., Polak, J. M. and Bloom, S. R. (1977). The newer gut hormones: cellular sources, physiology, pathology, and clinical aspects. Gastroenterology, 72, 746
Gold, P. and Freedman, S. O. (1965). Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp. Med., 121, 439
Gold, P. and Freedman, S. O.(1965). Specific carcinoembryonic antigens of the human digestive system. Exp. Med., 122, 467
Slayter, H. S. and Coligan, J. E. (1975). Electron microscopy and physical characterization of the carcinoembryonic antigen. Biochemistry, 14, 2323
Fuks, A., Banjo, C., Shuster, J., Freedman, S. O. and Gold, P. (1974). Carcinoembryonic antigen (CEA): molecular biology and clinical significance. Biochem. Biophys. Acta, 417, 123
Gold, J. M., Freedman, S. O. and Gold, P. (1972). Human antibodies detected by radioim-munoelectrophoresis. Nature New Biol, 239, 60
Costanza, M. E., Pinn, V., Schwartz, R. S. and Nathanson, L. (1973). Carcinoembryonic antigen antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N. Engl J. Med., 289,520
Rogers, G. T., Searle, F. and Bagshawe, K. D. (1974). Heterogeneity of carcinoembryonic antigen and its fractionation by con A affinity chromatography. Nature, 251, 519
Vrba, R., Alpert, E. and Isselbacher, K. J. (1975). Carcinoembryonic antigen: evidence for multiple antigenic determinants and isoantigens. Proc. Nat. Acad. Sci. USA, 72, 4602
Vrba, R., Alpert, E. and Isselbacher, K. J. (1976). Immunological heterogeneity of serum carcinoembronic antigen (CEA). Immunochemistry 13, 87
Edgington, T. S., Astarita, R. W. and Plow, E. F. (1975). Association of an isomeric species of carcinoembryonic antigen with neoplasia of the gastrointestinal tract. N. Engl J. Med., 293, 103
Plow, E. F. and Edgington, T. S. (1975). Isolation and characterization of a homogeneous isomeric species of a carcinoembryonic antigen: CEA-S. Int. J. Cancer, 15, 748
Egan, M. L., Pritchard, D. G., Shively, J. E. and Go, V. L. W. (1977) CEA-like substance in normal colon washings. Proc. Ann. Assoc. Cancer Res., 18, 40
Hansen, J. H., Snyder, J. J., Miller, E., Vandevoorde, J. P., Neal Miller, O., Hines, L. R. and Bums, J. J. (1974). Carcinoembryonic antigen (CEA) assay. Human Pathol, 5,139
Lawrence, D. J. R., Stevens, V., Bettelheim, R., Darcy, D., Leese, C., Tuberville, C., Alexander, P., Johns, E. W. and Neville, A. M. (1972). Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal mammary and bronchial carcinoma. Br. Med. J., 3, 605
Vincent, R. G., Chu, T. M., Fergen, T. B., Ostrander, M. (1975). Carcinoembryonic antigen in 228 patients with carcinoma of the lung. Cancer, 36, 2069
Abelev, G. I. (1971). Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv. Cancer Res., 14, 295
Nishi, S., Watabe, H. and Hirai, H. (1975). Immunological and chemical correlation between alpha-fetoproteins from humans and several mammalian species. Ann. N. Y. Acad. Sci., 259, 109
Ruoslahti, E. and Terry, W. D. (1976). Alpha-fetoprotein and serum albumin show sequence homology. Nature, 260, 804
Uriel, J., Bouillon, D., Aussei, C. and Dupiers, M. (1976). Alpha-fetoprotein: the major highaffinity estrogen binder in rat uterine cytosols. Proc. Nat. Acad. Sci. USA, 73, 1452
Uriel, J., Bouillon, D. and Dupiers, H. (1975). Afl[inity chromatography of human, rat and mouse a-fetoprotein on estradiol-sepharose absorbents. FEBS Letters, 53, 305.
Murgita, R. A. and Tomasi, T. B. (1975). The effect of mouse a-fetoprotein on mixed lymphocyte reactivity and mitogen-induced lymphocyte transformation, Æ’ Exp. Med., 141, 440
Parmely, M. J. and Thompson, J. S. (1976). Effects of a-fetoprotein and other serum factors derived from hepatoma-bearing rats on lymphocyte response, y. Immunol, 117, 1832
Charpentier, B., Guttmann, R. D., Shuster, J. and Gold, P. (1977). Augmentation of proliferation of human mixed lymphocyte culture by human alpha-fetoprotein. J. Immunol (In press)
Silver, H. K. B., Gold, P., Feder, S., Freedman, S. O. and Shuster, J. (1973). Radioimmunoassay for human alpha-fetoprotein. Proc. Natl Acad. Sci., 70, 526
Hirai, H., Nishi, S., Watabe, H. and Tsukada, Y. (1973). Some chemical, experimental, and clinical investigations of a-fetoproteins. Gann Monogr. Cancer Res., 14,19
Ruoslahti, E., Pihko, H. and Seppala, M. (1974). Alpha-fetoprotein immunochemical purification and chemical properties. Expression in normal states and in malignant and non-malignant liver disease. Transpl Res., 20, 38
Silver, H. K. B., Gold, P., Shuster, J., Javitt, N. B., Freedman, S. O. and Finlayson, N. D. C. (1974). Alpha-fetoprotein in chronic liver disease. N. Engl J. Med., 291, 506
Berk, P. D., Jones, E. A., Plötz, P. H., Seeff, L. B. and Wright, E. C. (1976). Corticosteroid therapy for chronic active hepatitis. Int. Med., 85, 523
Silver, H. K. B., Deneault, J., Gold, P., Thompson, W. G., Shuster, J. and Freedman, S. O. (1974). The detection of alpha-fetoprotein in patients with viral hepatitis.
Waldmann, T. A. and Mclntyre, K. R. (1972). Serum alpha-fetoprotein levels in patients with ataxia-telangiectasia. Lancet, ii, 1112
Milunsky, A. and Alpert, E. (1976). Prenatal diagnosis of neural tube defect. I. Problems and pitfalls: analysis of 2495 cases using alpha-fetoprotein assay Obstet. Gynecol, 48, 1
Milunsky, A. and Alpert, E. (1976). Prenatal diagnosis of neural tube defects. II. Analysis of false-positive and false-negative alpha-fetoprotein results. Obstet. Gynecol 48, 6
Horwitz, D. A. and Garrett, M. A. (1977). Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes and monocytes. J. Immunol, 118,1712
Greenberg, B. R., Peter, C. R., Glassy, F. and MacKenzie, M. R. (1976). A case of T-cell lymphoma with convoluted lymphocytes. Cancer, 38, 1602
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 MTP Press Limited
About this chapter
Cite this chapter
Shuster, J., Thomson, D.M.P., Gold, P. (1978). Immunodiagnosis. In: Castro, J.E. (eds) Immunological Aspects of Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-9418-4_12
Download citation
DOI: https://doi.org/10.1007/978-94-010-9418-4_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-9420-7
Online ISBN: 978-94-010-9418-4
eBook Packages: Springer Book Archive